跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIORESAL intrathecal baclofen 50 microgram/1 mL injection - TGA Drug Approval Details
Approvals
/
TGA
/
LIORESAL intrathecal baclofen 50 microgram/1 mL injection
Approved
STANDARD
LIORESAL intrathecal baclofen 50 microgram/1 mL injection
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
6ea55bfe584db528
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
6ea55bfe584db528
Product Name
LIORESAL intrathecal baclofen 50 microgram/1 mL injection
Artg Id
53837
Artg Name
LIORESAL intrathecal baclofen 50 microgram/1 mL injection ampoule
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
1996-03-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4d9b4016f8b17c12dbf341f48be8a007.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1b1fb117c56d9526e7423cdd81a3fa6c.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
6ea55bfe584db528
Type
Standard
Back to TGA Approvals
